BR9708656A - Barra suplementar para diabéticos - Google Patents

Barra suplementar para diabéticos

Info

Publication number
BR9708656A
BR9708656A BR9708656-8A BR9708656A BR9708656A BR 9708656 A BR9708656 A BR 9708656A BR 9708656 A BR9708656 A BR 9708656A BR 9708656 A BR9708656 A BR 9708656A
Authority
BR
Brazil
Prior art keywords
weight
approximately
diabetics
supplementary
supplementary bar
Prior art date
Application number
BR9708656-8A
Other languages
English (en)
Inventor
Stacey J Bell
Robert C Jones
R Armour Forse
Bruce R Bistrian
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/815,595 external-priority patent/US5866555A/en
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of BR9708656A publication Critical patent/BR9708656A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"BARRAS SUPLEMENTAR PARA DIABéTICOS", nova barra suplementar para diabéticos que inclui aproximadamente 10-60%, em peso, de carboidrato simples, aproximadamente 1-25%, em peso, de proteina, aproximadamente 2-40%, em peso, de lipidio e aproximadamente 1-60%, em peso, preferivelmente aproximadamente 5-35%, em peso, de carboidrato complexo. Esta formulação é particularmente útil para o tratamento ou a prevenção de hipoglicemia num paciente diabético dependente que requer injeções de insulina.
BR9708656-8A 1996-04-12 1997-03-28 Barra suplementar para diabéticos BR9708656A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63158496A 1996-04-12 1996-04-12
US08/815,595 US5866555A (en) 1997-03-12 1997-03-12 Diabetic supplement bar
PCT/US1997/005316 WO1997038593A1 (en) 1996-04-12 1997-03-28 Diabetic supplement bar

Publications (1)

Publication Number Publication Date
BR9708656A true BR9708656A (pt) 2000-01-04

Family

ID=27091433

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708656-8A BR9708656A (pt) 1996-04-12 1997-03-28 Barra suplementar para diabéticos

Country Status (8)

Country Link
US (1) US6156738A (pt)
EP (1) EP0896516A1 (pt)
JP (1) JP2000509258A (pt)
CN (1) CN1092938C (pt)
AU (1) AU2556897A (pt)
BR (1) BR9708656A (pt)
IL (1) IL126474A (pt)
WO (1) WO1997038593A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843921A (en) 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US6905702B1 (en) 1999-11-08 2005-06-14 Children's Hospital Los Angeles Methods for regulating blood glucose and appetite suppression in type 2 diabetics
WO2001033976A1 (en) * 1999-11-08 2001-05-17 Childrens Hospital Los Angeles Research Institute Methods for regulating blood glucose and appetite suppression in type 2 diabetics
US6569445B2 (en) 2000-12-05 2003-05-27 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements and anti-constipation and regularity maintaining-agents
US6576253B2 (en) * 2000-12-05 2003-06-10 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
WO2003016609A2 (en) * 2001-08-21 2003-02-27 Sara Lee Corporation Systems and methods for manufacturing
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US6916796B2 (en) * 2002-06-12 2005-07-12 Abbott Laboratories Use of pullulan as a slowly digested carbohydrate
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US20050058766A1 (en) * 2003-09-11 2005-03-17 Han Chung Wan Anti-diabetic diet and method for providing a proportioned ground food
US20050058759A1 (en) * 2003-09-15 2005-03-17 Schmidt James Carl Protein enhanced low carbohydrate snack food
WO2006058181A2 (en) * 2004-11-24 2006-06-01 Myprint Corporation Publication system
US8486469B2 (en) * 2005-10-17 2013-07-16 Intercontinental Great Brands Llc Low-calorie food bar
CN100345589C (zh) * 2005-12-29 2007-10-31 中国人民解放军第二军医大学 一种肠内要素营养制剂
FR2900342B1 (fr) * 2006-04-27 2010-08-20 Cie Laitiere Europeenne Utilisation de l'alpha-lactalbumine pour la regulation de la glycemie
ES2674369T3 (es) * 2007-04-02 2018-06-29 Nestec S.A. Composiciones alimenticias que incorporan triglicéridos de cadena media
US8071143B2 (en) * 2008-04-02 2011-12-06 Brandeis University Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
WO2010097484A2 (es) * 2009-02-25 2010-09-02 Productos Carnicos Elaborados Con Aceite De Oliva Virgen, S.L. Composición alimentaria
CN102378632A (zh) * 2009-04-03 2012-03-14 雀巢产品技术援助有限公司 对促进健康的追赶生长的改进
CN102791264B (zh) * 2010-03-31 2014-09-03 日清奥利友集团株式会社 用于预防或治疗糖尿病的油脂组合物
PL396649A1 (pl) * 2011-10-14 2013-04-15 Tomasz Banasiewicz Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce
CN102552385A (zh) * 2011-12-18 2012-07-11 西安泰科迈医药科技有限公司 一种治疗糖尿病纯中药药物组合及其制备方法
JP6603133B2 (ja) 2013-02-06 2019-11-06 ブランダイス ユニバーシティー ヤシ果実を用いたｄｎａ損傷およびミトコンドリア機能障害の治療
CN104643039A (zh) * 2013-11-21 2015-05-27 吴光平 一种益于糖尿病人食用的食膳

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220666A (en) * 1978-02-03 1980-09-02 Desert Merchandising, Inc. Sucrose-invert sugar protein product and method of manufacture
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4496606A (en) * 1983-04-29 1985-01-29 Nabisco Brands, Inc. Guar gum food bar
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5169662A (en) * 1989-08-31 1992-12-08 New Generation Foods, Inc. Dietary product and method for manufacture
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5187154A (en) * 1990-12-13 1993-02-16 Board Of Regents, The University Of Texas System Diagnosis and treatment of humans with diabetes or at risk to develop diabetes
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
CA2110565A1 (en) * 1992-12-04 1994-06-05 Robert Louis Joseph Nutritional bar for a protein-sparing diet of the very-low-calorie type
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5360614A (en) * 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
IL112967A0 (en) * 1994-03-15 1995-06-29 Los Angeles Childrens Hospital Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
JP3490455B2 (ja) * 1995-06-30 2004-01-26 シープロ インコーポレイティド 固形経口診断用試験食及びその利用方法
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5612074A (en) * 1995-12-21 1997-03-18 Leach; Robin L. Nutrient fortified food bar
AU720797B2 (en) * 1996-02-09 2000-06-15 Societe Des Produits Nestle S.A. Nutrient composition for exercise

Also Published As

Publication number Publication date
AU2556897A (en) 1997-11-07
IL126474A0 (en) 1999-08-17
EP0896516A1 (en) 1999-02-17
WO1997038593A1 (en) 1997-10-23
IL126474A (en) 2001-03-19
CN1092938C (zh) 2002-10-23
JP2000509258A (ja) 2000-07-25
US6156738A (en) 2000-12-05
CN1215311A (zh) 1999-04-28

Similar Documents

Publication Publication Date Title
BR9708656A (pt) Barra suplementar para diabéticos
Cappelleri et al. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes.
Wilton Tegretol in the treatment of diabetic neuropathy
CY1112034T1 (el) Μονοδιασπαρμενα μειγματα και μεθοδοι για την θεραπευτικη αγωγη του διαβητη
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
NO20003051L (no) Metode for administrering av AspB28-humant insulin
PT998288E (pt) Composicoes contendo capsaicina ou analogos de capsaicina e um anestesico local
KR920019342A (ko) 골질환 치료제
Habib Tetanus complicating snakebite in northern Nigeria:: clinical presentation and public health implications
BRPI0502691A (pt) composição farmacêutica para o controle da glicose no sangue de pacientes com diabetes tipo 2
EP1298203A3 (en) Diagnosis and treatment of autoimmune diseases
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
NO973548L (no) Behandling av diabetisk neuropati
NO931886L (no) Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning
KR960030947A (ko) src SH2 특이성 화합물의 골흡수 질환 치료 용도
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
Gallagher et al. A retrospective health economic analysis of a stable hypochlorous acid preserved wound cleanser versus 0.9% saline solution as instillation for negative-pressure wound therapy in severe and infected wounds
Cho et al. Perceptions of adequacy and job performance of nurse assistant nursing jobs according to registered nurses and nurse assistants in geriatric hospitals, and caregivers
Üreyen et al. Myocardial infarction after ozone therapy: is ozone therapy Dr. Jekyll or Mr. Hyde?
BRPI0409387A (pt) método para o tratamento de doença de tecido mole em um indivìduo mamìfero, composição farmacêutica, complexo de alvejamento de tecido mole, método para a formação de um complexo, e, kit para uso em um método
EA200301041A1 (ru) Стимуляция остеогенеза с использованием гибридных белков лиганда для rank
Vela et al. The use of treatment modality specific analysis according to Selwood in epidemiological studies.
ATE408629T1 (de) Verwendung von cd25-bindender moleküle für patienten mit steroide-resistenz
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
Nelson et al. Absence of exogenous retroviruses in Felty's syndrome

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/17 (2016.01), A23L 33/10 (2016.0